Liquid Biopsy Market USD 6.39 Billion in 2025 to USD 25.43 Billion by 2035

The liquid biopsy market is transforming the landscape of cancer diagnostics and monitoring. Unlike traditional biopsy procedures, which are invasive and often painful, liquid biopsies offer a non-invasive method to detect cancer through blood samples. This innovation has significantly improved patient experience while enabling faster, more accurate detection of various cancer types. By analyzing circulating …

Liquid Biopsy Market to Reach USD 3.6 Billion in 2025 and Surge to USD 19.7 Billion by 2035

The liquid biopsy market is emerging as a revolutionary force in the field of medical diagnostics and oncology. Liquid biopsy refers to a non-invasive technique that analyzes biomarkers, such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), or other molecular signatures, from bodily fluids like blood, urine, or saliva. This approach offers a promising …